Nikolsky Eugenia, Mehran Roxana, Halkin Amir, Aymong Eve D, Mintz Gary S, Lasic Zoran, Negoita Manuela, Fahy Martin, Krieger Shoshana, Moussa Issam, Moses Jeffrey W, Stone Gregg W, Leon Martin B, Pocock Stuart J, Dangas George
Cardiovascular Research Foundation and the Lenox Hill Heart and Vascular Institute, New York, New York 10022, USA.
J Am Coll Cardiol. 2004 Sep 15;44(6):1200-9. doi: 10.1016/j.jacc.2004.06.048.
This study was designed to assess the safety of arteriotomy closure devices (ACDs) versus mechanical compression by meta-analysis in patients undergoing percutaneous transfemoral coronary procedures.
Although ACDs are widely applied for hemostasis after percutaneous endovascular procedures, their safety is controversial.
Randomized, case-control, and cohort studies comparing access-related complications using ACDs versus mechanical compression were analyzed. The primary end point was the cumulative incidence of vascular complications, including pseudoaneurysm, arteriovenous fistula, retroperitoneal hematoma, femoral artery thrombosis, surgical vascular repair, access site infection, and blood transfusion.
A total of 30 studies involving 37,066 patients were identified. No difference in complication incidence between Angio-Seal and mechanical compression was revealed in the diagnostic (Dx) setting (odds ratio [OR] 1.08, 95% confidence interval [CI] 0.11 to 10.0) or percutaneous coronary interventions (PCI) (OR 0.86, 95% CI 0.65 to 1.12). Meta-analysis of randomized trials only showed a trend toward less complications using Angio-Seal in a PCI setting (OR 0.46, 95% CI 0.20 to 1.04; p = 0.062). No differences were observed regarding Perclose in either Dx (OR 1.51, 95% CI 0.24 to 9.47) or PCI (OR 1.21, 95% CI 0.94 to 1.54) setting. An increased risk in complication rates using VasoSeal in the PCI setting (OR 2.25, 95% CI 1.07 to 4.71) was found. The overall analysis favored mechanical compression over ACD (OR 1.34, 95% CI 1.01 to 1.79).
In the setting of Dx angiography, the risk of access-site-related complications was similar for ACD compared with mechanical compression. In the setting of PCI, the rate of complications appeared higher with VasoSeal.
本研究旨在通过荟萃分析评估在接受经皮股动脉冠状动脉介入手术的患者中,动脉切开闭合装置(ACD)与机械压迫止血的安全性。
尽管ACD已广泛应用于经皮血管内手术后的止血,但它们的安全性仍存在争议。
分析比较使用ACD与机械压迫止血的相关血管并发症的随机对照试验和队列研究。主要终点是血管并发症的累积发生率,包括假性动脉瘤、动静脉瘘、腹膜后血肿、股动脉血栓形成、外科血管修复、穿刺部位感染和输血。
共纳入30项研究,涉及37066例患者。在诊断性血管造影(Dx)或经皮冠状动脉介入治疗(PCI)中,Angio-Seal与机械压迫止血在并发症发生率上无差异(优势比[OR]1.08,95%置信区间[CI]0.11至10.0)或PCI(OR 0.86,95%CI 0.65至1.12)。仅对随机试验的荟萃分析显示,在PCI中使用Angio-Seal有并发症更少的趋势(OR 0.46,95%CI 0.20至1.04;p = 0.062)。在Dx(OR 1.51,95%CI 0.24至9.47)或PCI(OR 1.21,95%CI 0.94至1.54)中,Perclose均未观察到差异。在PCI中使用VasoSeal并发症发生率增加(OR 2.25,95%CI 1.07至4.71)。总体分析表明机械压迫优于ACD(OR 1.34,95%CI 1.01至1.79)。
在Dx血管造影中,ACD与机械压迫止血相比,穿刺部位相关并发症的风险相似。在PCI中,VasoSeal的并发症发生率似乎更高。